#NEWS : Today we announced, in collaboration with AstraZenecaUS, topline results from the DESTINY-Breast06 phase 3 trial in patients with HER2 low or ultralow metastatic #BreastCancer . Click the image to learn more.

It helps to have a support system when navigating a life with acute myeloid #leukemia (AML). Today we honor both those living with this aggressive blood cancer and their caregivers. #AMLWorldAwarenessDay

#NEWS : Our HER2 directed medicine, in collaboration w/ AstraZenecaUS, is the first of its kind to receive a tumor agnostic indication in the U.S. Click the image to learn more.

#NEWS : We have initiated the REJOICE-Ovarian01 phase 2/3 trial for certain adult patients with platinum-resistant #ovariancancer in collaboration with Merck. Click the image to learn more.

The U.S. FDA has accepted the BLA for our TROP2 directed #ADC , in collaboration w/ AstraZenecaUS, for the treatment of certain adult patients with unresectable or metastatic HR+, HER2- #breastcancer who have received prior therapy. Click the image for more information.

Our US CEO and Global Head of the Oncology Business shares his 10-year journey at Daiichi Sankyo US. Learn more about why Daiichi Sankyo has been “an adventure of limitless opportunity” for Ken Keller.

For #WomensHistoryMonth we spoke w/ Dalal Nesheiwat, PharmD, Vice President, Global Head of Clinical Science at Daiichi Sankyo US, who reflects on the profound impact her family had on her life & how they serve as role models as she works to “send the elevator back down” herself.

A proud Puerto Rican woman in #STEM , Yira says that clinical trial patients are the reason for her drive. Serving as a translator to Spanish-speaking patients in clinical and pre-clinical work was just one was she got to do what she loves. #WomensHistoryMonth2024

How do YOU #InspireInclusion ? Celebrate International Women's Day with us as we honor the achievements of women worldwide and the work that still lies ahead. #IWD2024

Thank you BioNJ for your dedication to patients & showcasing innovation within life sciences. We are honored to be recognized for our efforts to advance treatment options for certain adult patients w/ newly diagnosed acute myeloid leukemia ( #AML ) w/ an Innovator Award.

Leading programs at Daiichi Sankyo US aimed at impacting diverse communities, Stephen Agyenim-Boateng, Medical Science Liaison, Oncology believes “by showing up, we can achieve change in our communities.” #DSProud #BlackHistoryMonth #YBP

Today, on #RareDiseaseDay , let’s unite in raising awareness and supporting those impacted by rare diseases worldwide. Every voice matters in advocating for research, treatments and hope. #ShowYourStripes

Our “Walk a Mile” #InTheirShoes initiative provides an opportunity to meet patients and advocates where they are in their cancer journeys, even at a marathon. Team LUNGevity Foundation is one of many groups we support – and cheer on – as they raise funds for #LungCancer research.

We’re looking forward to attending @Biocom-California’s Global Life Science Partnering & Investor Conference this week and connecting with various thought leaders across life sciences all coming together to help improve the human condition. #BiocomGPIC

Jenn Knight, BSN, RN became a heart attack survivor just over 1 year ago. Today she’s making a difference as an American Heart Association Women of Impact nominee—educating her community about heart disease, CPR and more—and showcasing the power of passion and purpose #HeartMonth

A 4x Track and Field Olympian, author and entrepreneur, @NewJoetta knows what it takes to be a champion. This Black History Month, she shared her remarkable journey with us, and showed how embracing opportunity, leadership and learning lead to legacy. #BlackHistoryMonth

“It was incredible how these doctors & nurses were able to repair this broken heart, no bigger than a walnut.” Michael Grosso, VP, Global Head of Specialty Medicine Development at Daiichi Sankyo discusses life as a former heart surgeon & his fulfilling career. #Heartmonth

Overwhelmed after receiving a #BreastCancer diagnosis, Viola Wang found support with Unite for HER. Today, she serves on its Task Force for Women of Color and openly shares her story to empower survivors and the broader Asian Community. #InTheirShoes

The U.S. FDA has accepted the BLA for our TROP2 directed DXd #ADC , in collaboration w/ AstraZenecaUS, for the treatment of adult patients w/ locally advanced or metastatic nonsquamous #NSCLC who have received prior systemic therapy. Click the image for more information.

Caring for someone at their most vulnerable is a selfless act that makes an enormous difference. Thank you to each and every caregiver for all that you do.  #NationalCaregiversDay